Skip to content

Canada’s international development minister urges WHO to approve Medicago vaccine

Canada intends to donate 20 million doses, which can only happen if WHO approve that vaccine
28533964_web1_20220321130352-6238bc2ebddac24962bd7efejpeg
A vial of a plant-derived COVID-19 vaccine candidate, developed by Medicago, is shown in Quebec City on Monday, July 13, 2020 as part of the company’s Phase 1 clinical trials in this handout photo. International Development Minister Harjit Sajjan says he wants the World Health Organization to greenlight Medicago’s COVID-19 vaccine so it can be donated and used by the COVAX vaccine sharing alliance. THE CANADIAN PRESS/HO, Medicago *MANDATORY CREDIT*

International Development Minister Harjit Sajjan says he wants the World Health Organization to greenlight Medicago’s COVID-19 shot so it can be donated and used by the COVAX vaccine-sharing alliance.

But he says Canada’s ability to get more doses out the door to lower-income countries depends mostly on getting reassurance they can and will be used when they are sent.

Canada is promising to donate at least 200 million doses by the end of the year but only 15 million have been delivered so far.

Fewer than two million doses were shipped out this year and Sajjan says more can go as soon as recipient countries indicate they’re ready for them.

On paper, Canada should have close to 100 million more doses available for donation that were purchased for Canadians that cannot be used here.

But half are the Novavax vaccine Canada has yet to confirm will be donated, and 20 million come from Medicago, which can only be donated if WHO agrees to approve that vaccine despite the company’s ties to big tobacco.

—The Canadian Press

RELATED: Bump in COVID-19 cases ‘not unexpected’ as health measures lifted, Tam says

RELATED: WHO may reject Canadian-made Medicago COVID-19 vaccine because of ties to big tobacco